Insulin resistance in women's health: Why it matters and how to identify it

Current Opinion in Obstetrics and Gynecology

Volumn 21, Issue 4, 2009, Pages 301-305

  Legro, Richard S ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Diabetes; Metabolic syndrome

Indexed keywords

ALLELE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE MARKER; ENVIRONMENTAL FACTOR; HUMAN; INSULIN RESISTANCE; LIFESPAN; METABOLIC SYNDROME X; MORBIDITY; NEWBORN DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; OBESITY; PERINATAL CARE; POPULATION SURVEILLANCE; PRE-ECLAMPSIA; PREGNANCY; REPRODUCTION; RISK FACTORS; WOMEN'S HEALTH;

EID: 68949173744     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/GCO.0b013e32832e07d5     Document Type: Review

References (43)

1. Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA. One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 2008; 31:1650-1655.
2. SattarN, McConnachieA, Shaper AG, etal. Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008; 371:1927-1935.
3. Manley SE, Luzio SD, Stratton IM, et al. Preanalytical, analytical, and computational factors affect homeostasis model assessment estimates. Diabetes Care 2008; 31:1877-1883.
4. Goran MI, Lane C, Toledo-Corral C, Weigensberg MJ. Persistence of pre-diabetes in overweight and obese Hispanic children: association with progressive insulin resistance, poor beta-cell function, and increasing visceral fat. Diabetes 2008; 57:3007-3012.
5. Hivert MF, Sullivan LM, Fox CS, et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008; 93:3165-3172.
6. Swarbrick MM, Stanhope KL, Austrheim-Smith IT, etal. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia 2008; 51:1901-1911.
7. Joosten MM, Beulens JW, Kersten S, Hendriks HF. Moderate alcohol consumption increases insulin sensitivity and ADIPOQ expression in postmeno-pausal women: a randomised, crossover trial. Diabetologia 2008; 51:1375-1381.
8. Cambuli VM, Musiu MC, Incani M, etal. Assessment of adiponectin and leptin as biomarkers of positive metabolic outcomes after lifestyle intervention in overweight and obese children. J Clin Endocrinol Metab 2008; 93:3051-3057.
9. Georgiou HM, Lappas M, Georgiou GM, et al. Screening for biomarkers predictive of gestational diabetes mellitus. Acta Diabetol 2008; 45:157-165.
10. Sattar N, Nelson SM. Adiponectin, diabetes, and coronary heart disease in older persons: unraveling the paradox. J Clin Endocrinol Metab 2008; 93:3299-3301.
11. Brudevold R, Hole T, Hammerstrom J. Hyperferritinemia is associated with insulin resistance and fatty liver in patients without iron overload. PLoS ONE 2008; 3:e3547.
12. Hall MH, Muldoon MF, Jennings JR, et al. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep 2008; 31:635-643.
13. Tasali E, Van Cauter E, Ehrmann DA. Relationships between sleep disordered breathing and glucose metabolism in polycystic ovary syndrome. J Clin Endocrinol Metab 2006; 91:36-42.
14. Nakra N, Bhargava S, Dzuira J, et al. Sleep-disordered breathing in children with metabolic syndrome: the role of leptin and sympathetic nervous system activity and the effect of continuous positive airway pressure. Pediatrics 2008; 122:e634-e642.
15. Meigs JB, Shrader P, Sullivan LM, et al. Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008; 359:2208-2219.
16. Lyssenko V, Jonsson A, Almgren P, et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 2008; 359:2220-2232.
17. Moore AF, Jablonski KA, McAteer JB, et al. Extension of type 2 diabetes genome-wide association scan results in the Diabetes Prevention Program. Diabetes 2008; 57:2503-2510.
18. Semple RK, Sleigh A, Murgatroyd PR, etal. Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 2009; 119:315-322.
19. Ciaraldi TP, Aroda V, Mudaliar S, et al. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J Clin Endocrinol Metab 2009; 94:157-163.
20. Lang IA, Galloway TS, Scarlett A, et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008; 300:1303-1310.
21. Peretz A, Sullivan JH, Leotta DF, et al. Diesel exhaust inhalation elicits acute vasoconstriction in vivo. Environ Health Perspect 2008; 116:937-942.
22. Chang PC, Li TC, Wu MT, et al. Association between television viewing and the risk of metabolic syndrome in a community-based population. BMC public health 2008; 8:193.
23. Sanchez-Chaparro MA, Calvo-Bonacho E, Gonzalez-Quintela A, etal. Occupation-related differences in the prevalence of metabolic syndrome. Diabetes Care 2008; 31:1884-1885.
24. Sierra-Johnson J, Unden AL, Linestrand M, et al. Eating meals irregularly: a novel environmental risk factor for the metabolic syndrome. Obesity (Silver Spring) 2008; 16:1302-1307.
25. Beydoun MA, Gary TL, Caballero BH, et al. Ethnic differences in dairy and related nutrient consumption among US adults and their association with obesity, central obesity, and the metabolic syndrome. Am J Clin Nutr 2008; 87:1914-1925.
26. Wei HJ, Young R, Kuo IL, et al. Abnormal preconception oral glucose tolerance test predicts an unfavorable pregnancy outcome after an in vitro fertilization cycle. Fertil Steril 2008; 90:613-618.
27. Vikse BE, Irgens LM, Leivestad T, etal. Preeclampsia and the risk of end-stage renal disease. N Engl J Med 2008; 359:800-809.
28. Lampinen KH, Ronnback M, Groop PH, Kaaja RJ. A relationship between insulin sensitivity and vasodilation in women with a history of preeclamptic pregnancy. Hypertension 2008; 52:394-401.
29. Isezuo SA, Ekele BA. Comparison of metabolic syndrome variables among pregnant women with and without eclampsia. J Natl Med Assoc 2008; 100:1059-1062.
30. Vantyghem MC, Vincent-Desplanques D, Defrance-Faivre F, etal. Fertility and obstetrical complications in women with LMNA-related familial partial lipody-strophy. J Clin Endocrinol Metab 2008; 93:2223-2229.
31. Hubel CA, Powers RW, Snaedal S, et al. C-reactive protein is elevated 30 years after eclamptic pregnancy. Hypertension 2008; 51:1499-1505.
32. Smith GN, Walker MC, Liu A, et al. A history of preeclampsia identifies women who have underlying cardiovascular risk factors. Am J Obstet Gynecol 2009; 200:58.e1 -58.e8.
33. Berends AL, de Groot CJ, Sijbrands EJ, et al. Shared constitutional risks for maternal vascular-related pregnancy complications and future cardiovascular disease. Hypertension 2008; 51:1034-1041.
34. Recabarren SE, Smith R, Rios R, etal. Metabolic profile in sons of women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 2008; 93:1820-1826.
35. Kent SC, Gnatuk CL, Kunselman AR, et al. Hyperandrogenism and hyper-insulinism in children of women with polycystic ovary syndrome: a controlled study. J Clin Endocrinol Metab 2008; 93:1662-1669.
36. Kinra S, Sarma KVR, Ghafoorunissa, et al. Effect of integration of supplemental nutrition with public health programmes in pregnancy and early childhood on cardiovascular risk in rural Indian adolescents: long term follow-up of Hyderabad nutrition trial. BMJ 2008; 337:a605.
37. Gardner DS, Hosking J, Metcalf BS, etal. Contribution of early weight gain to childhood overweight and metabolic health: a longitudinal study (EarlyBird 36). Pediatrics 2009; 123:e67-e73.
38. Rotteveel J, van Weissenbruch MM, Twisk JW, Delemarre-Van de Waal HA. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics 2008; 122:313-321.
39. Cussons AJ, Watts GF, Burke V, etal. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod 2008; 23:2352-2358.
40. Rossi B, Sukalich S, Droz J, et al. Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome. J Clin Endocrinol Metab 2008; 93:4780-4786.
41. Ketel IJ, StehouwerCD, Serne EH, etal. Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and micro-vascular insulin resistance. J Clin Endocrinol Metab 2008; 93:3365-3372.
42. Janssen I, Powell LH, Crawford S, et al. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med 2008; 168:1568-1575.
43. Michelsen TM, Pripp AH, Tonstad S, et al. Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study. Eur J Cancer 2009; 45: 82-89.